NASDAQ:FLDM »
-
Company News » Fluidigm’s JunoTM System Wins Gold at the 8th Annual International Design Awards CompetitionBusiness Wire - June 3, 2015, 13:07 GMTFluidigm Corporation (NASDAQ:FLDM) announced that its JunoTM system, an advanced platform for genotyping and sample prep, was a Gold Award winner in the Industrial and Life Science Design – Medical/Scientific Machinery category at the 8th Annual International Design Awards competition. The International Design Awards (IDA) was created in 2007 to identify and celebrate smart, sustainable
-
Company News » Fluidigm Brings Automated Targeted Library Prep to JunoBusiness Wire - May 27, 2015, 13:10 GMT
Fluidigm Corporation (NASDAQ:FLDM) will disclose details of its new automated library preparation application for targeted sequencing, optimized for its JunoTM system, at the upcoming European Human Genetics Conference in Glasgow, Scotland, June 6-9. The new library preparation application will expand genomic coverage capacity by an order of magnitude over current Fluidigm offerings. This application is
-
Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the first quarter ended March 31, 2015. Total revenue for the first quarter of 2015 was $26.7 million, an increase of 4% from $25.7 million in the first quarter of 2014, and an increase of 10% on a constant-currency basis. The first quarter of 2014 revenue
-
Fluidigm Corporation (NASDAQ:FLDM) has recruited industry veteran Steven C. McPhail to lead its new organization specifically focused on serving its production genomics customers. Production genomics remains a key strategic opportunity for Fluidigm to diversify the company’s product lines and end-customer mix. “For years, production genomics has been a growth driver for Fluidigm, and this opportunity
-
Company News » Fluidigm to Announce Q1 2015 Financial Results and Host Conference Call for InvestorsBusiness Wire - April 30, 2015, 13:02 GMT
Fluidigm Corporation (NASDAQ:FLDM) will report its first quarter 2015 financial results on May 7, 2015, after close of market. Gajus Worthington, Fluidigm president and chief executive officer, and Vikram Jog, chief financial officer, will host a conference call at 2:00 p.m. PDT (5:00 p.m. EDT) on May 7, 2015, to discuss first quarter 2015 financial
-
Company News » SNP Trace Panel Proves to Be a High-Throughput, Cost-Effective SNP-Based Platform for Profiling Human Tissue and Cell LinesBusiness Wire - February 25, 2015, 19:16 GMT
Researchers at Genentech, a member of the Roche Group, and Fluidigm Corporation have used the Fluidigm SNP TraceTM panel to generate a database of SNP profiles for 907 cancer cell lines as a resource for cell line authentication. This information was published in the current issue of the journal PLOS ONE in a paper entitled
-
Company News » Fluidigm to Present at the 35th Annual Cowen & Company Health Care ConferenceBusiness Wire - February 24, 2015, 14:04 GMT
Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Executive Officer and President Gajus Worthington will make overview remarks and participate in a Q&A session at the 35th Annual Cowen & Company Health Care Conference in Boston on Tuesday, March 3, 2015, from 11:20-11:50 a.m. (ET). Audio of Fluidigm’s presentation will be webcast at: http://wsw.com/webcast/cowen22/fldm. The webcast
-
Company News » Fluidigm Debuts Newest State-of-the-Art Single-Cell System at AGBTBusiness Wire - February 19, 2015, 14:05 GMT
Fluidigm Corporation (NASDAQ:FLDM) will provide attendees at the 16th annual Advances in Genome Biology and Technology (AGBT) meeting the first glimpse of PolarisTM, an integrated single-cell research system, in addition to other new products. This exciting new product is the first to integrate cell selection, isolation, dose, culture and molecular preparation into a single workflow,
-
Company News » Science for Life Laboratory Forms Swedish National Center for Single-Cell BiologyBusiness Wire - February 5, 2015, 21:06 GMT
Fluidigm Corporation (NASDAQ:FLDM) today announced that Science for Life Laboratory (SciLifeLab) has established the Swedish National Center for Single-Cell Biology. The center features six C1TM systems, three CyTOF(R) 2 systems and a BiomarkTM HD system, making SciLifeLab one of the preeminent users of the full line of Fluidigm’s single-cell technologies in the world. SciLifeLab is
-
Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2014. Total revenue for the fourth quarter of 2014 was $33.5 million, an increase of 60% from $20.9 million in the fourth quarter of 2013. Organic revenue for the fourth quarter of 2014 (excluding revenue attributable to
| Forex Broker Spreads » |
|
Iron FX
XM Markets
FxPro
FXCM